Drug giant Eli Lilly says its weight-loss drug tirzepatide helps people with obesity avoid getting diabetes, even months after stopping the medication. Excess weight increases the risk for diabetes ...

Eli Lilly’s popular weight loss drug, Zepbound, may reduce the risk of developing Type 2 diabetes by 94% in obese and overweight adults with prediabetes, according to preliminary results from a new ...

The weight-loss drugs that have become so popular in recent years actually began as diabetes medications, and a new study shows that they continue to provide strong protection against that chronic ...

Ozempic and Wegovy may have some new competition. Eli Lilly has announced that its new diabetes drug, Zepbound (tirzepatide), reduced the risk of developing Type 2 diabetes by 94% in prediabetic ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Hilary Brueck Every time Hilary publishes a story, you’ll get an alert straight to your inbox!